Steroid and Tacrolimus Avoidance Using NULOJIX® (Belatacept) in Renal Transplantation (CTOT-16)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01856257

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:54.196811+00:00

Published At

2017-08-07T00:00:00+00:00

Record Updated At

2020-12-17

Results Posted At

2017-08-07

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Renal Allograft Candidate", "Kidney Transplantation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2020-12-17"

protocolSection.identificationModule.nctId

"NCT01856257"

protocolSection.identificationModule.officialTitle

"Steroid and Tacrolimus Avoidance Using NULOJIX\u00ae (Belatacept) in Renal Transplantation (CTOT-16)"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-08-07"

Study condition terms

• Primary Renal Allograft Candidate (protocolSection.conditionsModule.conditions)
• Kidney Transplantation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.